'Long-Term Downside Options Positioning' in Express Scripts (ESRX) Following Cigna (CI) Deal News -Susquehanna

William Blair Downgrades Express Scripts (ESRX) to Market Perform Amid Merger Announcement

William Blair downgraded Express Scripts (NASDAQ: ESRX) from Outperform to Market Perform following merger announcement.

For an analyst ratings summary and ratings history on Express Scripts click here. For more ratings news on Express Scripts click here.

Shares of Express Scripts closed at $73.42 yesterday.

Jefferies Upgrades Express Scripts (ESRX) to Hold Following Acquisition

Jefferies upgraded Express Scripts (NASDAQ: ESRX) from Buy to Hold with a price target of $91.00.

For an analyst ratings summary and ratings history on Express Scripts click here. For more ratings news on Express Scripts click here.

Shares of Express Scripts closed at $73.42 yesterday.

Maxim Group Downgrades Express Scripts (ESRX) to Hold Following Acquisition

Maxim Group downgraded Express Scripts (NASDAQ: ESRX) from Buy to Hold.

For an analyst ratings summary and ratings history on Express Scripts click here. For more ratings news on Express Scripts click here.

Shares of Express Scripts closed at $73.42 yesterday.

Cigna/ESRX Deal Validates CVS's Aetna Deal, Mizuho Says; Walgreens (WBA) Watching and Amazon (AMZN) Threat Neutralized

Mizuho analyst Ann Hynes offered some thoughts on Cigna's (NYSE: CI) deal to acquire Express Scripts (NASDAQ: ESRX).

Hynes said the announcement validates both UnitedHealth Group (NYSE: UNH)... More

Humana (HUM), WellCare (WCG) Could See Weakness Following CI/ESRX Deal - Deutsche Bank

Deutsche Bank analyst Chris Rigg said Humana (NYSE: HUM) and WellCare (NYSE: WCG) could be negatively impacted as the investment community viewed each as potential targets of acquisition by Cigna (NYSE: CI), which is now obviously off the table given it acquired Express Scripts (NASDAQ: ESRX).

Wall Street rises as Trump softens tariff plan

By Sinéad Carew

NEW YORK (Reuters) - The three major U.S. stock indexes closed higher on Thursday after President Donald Trump appeared to soften his stance on trade tariffs, easing trade war fears that had had the market on edge for a week.

Trump announced import tariffs on steel and aluminum but said Canada and Mexico would be exempt and that other countries could apply for exemptions, although details of when they would be granted were thin.

This is something that bites less than what the rhetoric was last week," said Chuck Carlson, Chief... More

UnitedHealth Group (UNH) Could Loss Cigna's (CI) PBM Outsourcing Biz Amid Express Scripts (ESRX) Deal - Evercore ISI

Evercore ISI analyt Ross Muken notes UnitedHealth Group (NYSE: UNH) faces likely loss of Cigna's (NYSE: CI) PBM outsourcing business after it agreed to acquire Express Scripts (NASDAQ: ESRX), but they... More

Express Scripts (ESRX) puts active into Cigna (CI) acquiring in cash, stock transaction valued at about $67B

Express Scripts (NASDAQ: ESRX) March weekly call option implied volatility is at 34, March is at 29, April is at 28; compared to its 52-week range of 19 to 44 into Cigna (CI) acquiring in cash, stock transaction valued at about $67B. Call put ratio 1 call to 3.5 puts... More

Cigna (CI) to Acquire Express Scripts (ESRX) for $67 Billion

Cigna Corporation (NYSE: CI) and Express Scripts Holding Company (NASDAQ: ESRX) today announced that they have entered into a definitive agreement whereby Cigna will acquire Express Scripts in a cash and stock transaction valued at approximately $67 billion, including Cigna's assumption of approximately $15 billion in Express Scripts debt. The merger consideration will consist of $48.75 in cash and 0.2434 shares of stock of the combined company per Express Scripts share. The transaction was approved by the board of directors of each company.

Cignas acquisition of Express Scripts brings together two complementary... More

Health insurer Cigna to buy Express Scripts for about $52 billion

By Caroline Humer and Ankur Banerjee

(Reuters) - U.S. health insurer Cigna Corp (NYSE: CI) struck a $52-billion deal to buy pharmacy benefits manager (PBM) Express Scripts Holding Co (NASDAQ: ESRX) on Thursday, looking for new ways to hold onto their profits as the industry faces greater scrutiny for rising healthcare costs.

The pharmacy benefits business, which tries to negotiate down the price of prescription medicines for large employers, has drawn fire from the Trump administration and Congress, who have questioned whether those discounts are... More

Barclays Starts Express Scripts (ESRX) at Equalweight

Barclays initiates coverage on Express Scripts (NASDAQ: ESRX) with a Equalweight rating and a price target of $84.00.

For an analyst ratings summary and ratings history on Express Scripts click here. For more ratings news on Express Scripts click here.

Shares of Express Scripts closed at $73.42 yesterday.

Cigna Corp. (CI) Near Deal to Acquire Express Scripts (ESRX) - WSJ

Cigna Corp. (NYSE: CI) is near a deal to acquire Express Scripts (NASDAQ: ESRX) in a deal that could be valued at $50 billion, the Wall Street Journal reported late Wednesday.

A deal could be announced as soon as Thursday, the report stated.